Last reviewed · How we verify
Lidocaine Hydrochloride and Ketamine
Lidocaine Hydrochloride and Ketamine, marketed by Rajmonda Nallbani-Komoni, holds a position in the pharmaceutical market with a key composition patent expiring in 2028. The drug's key strength lies in its unique combination of lidocaine and ketamine, which differentiates it from other anesthetic and pain management options. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | Lidocaine Hydrochloride and Ketamine |
|---|---|
| Also known as | Lidocaine Hydrochloride ampule and Ketamine ampule |
| Sponsor | Rajmonda Nallbani-Komoni |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Cardiac Index and General Anesthesia Without Opioid. (PHASE2, PHASE3)
- Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfunction Undergoing Elective Coronary Artery Bypass (NA)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients (NA)
- Transition From Acute to Chronic Opioid Use and Chronic Pain (EARLY_PHASE1)
- The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain. (EARLY_PHASE1)
- Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lidocaine Hydrochloride and Ketamine CI brief — competitive landscape report
- Lidocaine Hydrochloride and Ketamine updates RSS · CI watch RSS
- Rajmonda Nallbani-Komoni portfolio CI